Understanding the safety profile helps you and your provider make informed decisions about the compound
In preclinical studies, exenatide-loaded microneedle patches showed results comparable to traditional subcutaneous injection in animal models
Weight loss effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with obesity without diabetes: A systematic review
The initial phase is, to a large extent, driven by reward ( 2.2 Several GLP-1R-containing brain regions regulate alcohol-mediated responses in rodents After systemic injections of the aforementioned GLP-1R agonists, the roles of central and peripheral receptors cannot be distinguished
Nat Prod Rep
Alex Azar, former Secretary of the US Department of Health and Human Services, noted that there is little stigma around taking a statin to manage high cholesterol, but using a GLP-1 to help with weight loss can be perceived by some as taking the easy way out. Panelists emphasized that this perception, despite its inaccuracy, persists and may stand in the way of patients accessing these effective treatments or staying on them long-term